CVTX - CV Therapeutics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (35)	3/23/2001 11:32:49 AM
From: keokalani'nui	Read Replies (1) of 411

Thanks rkrw. That leaves the issue of how effective. The way the company was lusted for before the enlargement of the current trial, the world surely thought the company meant "substantial" as well as 'significant', but they haven't really said that yet. At least as far as I can see. Of course, maybe all one needs to know is that they met the first PIII endpoints, p<.05, and the subset analyses angina/chf/diabetes all do also, without having to know how good. The improvement must have been mentioned at ACC. Anyone know much longer on the treadmill until time to angina vs. placebo? If the info is available out there, just link me. I never want others to do for me what I can do myself. Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next